Also, inhibition of miR-31 using CRISPR/Cas9 editing in myotubes derived from induced pluripotent stem cells (iPSCs) of DMD patients showed restoration of dystrophin (134). The gene discussed is DMD; the disease is Duchenne muscular dystrophy.